TEVA
Teva Pharmaceutical Industries Limited
NYSE · ILHealthcareDrug Manufacturers - Specialty & Generic
$31.00-3.22%
Price as of Jul 20, 2026
TEVA capital
Teva Pharmaceutical Industries Limited capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 2.05x
- Net debt / equity
- 1.60x
- Debt / assets
- 0.42x
- Debt / EBITDA
- 5.17x
- Net debt / EBITDA
- 4.03x
Liquidity & coverage
- Current ratio
- 1.01x
- Quick ratio
- 0.78x
- Cash ratio
- 0.28x
- Interest coverage
- 2.53x
- EBITDA / interest
- 3.61x
- Working capital
- $178.0M
Cash & dividend
- FCF / debt
- 0.07x
- Cash flow / debt
- 0.10x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.